Regulatory Insights

  1. Measuring What Can't Be Seen: How PTSD Clinical Trials Prove A Drug Works 5/22/2026

    PTSD trials expose one of the hardest problems in modern drug development, a reliance on clinician-administered and patient-reported scales to determine whether a therapy truly works.

  2. The Regulatory Governance Gap In Clinical Trial AI 5/21/2026

    Regulators are no longer questioning whether AI belongs in clinical trials; however, they’re demanding a governed infrastructure that makes every AI-driven decision auditable and defensible.

  3. Real-Time Review Is The Most Underrated FDA Story Of The Year 5/21/2026

    The FDA’s real-time review pilot signals a massive shift in clinical operations, where continuously regulator-ready data becomes the foundation of future trial execution.

  4. De-Risk Trials For Accelerated Approval And Pipeline Optimization 5/20/2026

    This e-book explores how AI-powered Historical Clinical Trial Data (HCTD) is reshaping modern trial design for oncology and rare disease research.

  5. Timing And Data Are Critical To Winning BTD For Rare Disease Drugs 5/20/2026

    Breakthrough Therapy designation (BTD) can accelerate rare disease drug development—but timing and evidence are everything. Learn how to position your program for FDA success.

  6. AI Meets Informed Consent: Opportunity, Risk, And What IRBs Need To See 5/14/2026

    Expert perspectives on IRB oversight, health literacy, and research ethics offer practical guidance to strengthen consent, protect participants, and align compliance with real-world research.

  7. What Sponsors Need To Know Before They Get To The IRB & IBC 5/13/2026

    Gene therapy requires early, rigorous safety planning and command of pediatric and biosafety rules. Early committee engagement reduces delays and strengthens high‑stakes trials.

  8. 5 Questions To Ask Before Selecting A Randomization Partner 5/12/2026

    Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.

  9. Building Integrated Clinical Strategies For Complex Modalities 5/12/2026

    Explore how integrated strategies, digital tools, and patient-centric trial models are helping advance complex cell and gene therapy development.

  10. How To Best Navigate The Global Clinical Trial Registry Ecosystem 5/12/2026

    This presentation is your GPS, guiding you on a path that includes harmonization initiatives intended to improve transparency and data consistency across registries.